Evidence map›Paper›PMID 25964731›Full record

ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation.

Popi Sifianou, Voula Thanou, Helen Karga

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03076775 (Fetal Metabolic Consequences of Late Preterm Steroid Exposure), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03076775 nacompletednot on this map

Fetal Metabolic Consequences of Late Preterm Steroid Exposure

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2017 to 2021Enrolled86ConditionsPregnancy Preterm, Neonatal Hypoglycemia, Hyperglycemia Drug InducedArmsMaternal glycemic control
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Betamethasone latency period and neonatal hypoglycemia in term infants.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids.Journal of perinatology : official journal of the California Perinatal Association · 2020
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Popi SifianouDepartment of Neonatology, General and Maternity Hospital Elena Venizelou, Athens, Greece.
Voula ThanouSecond Division of Endocrinology and Metabolism, Alexandra Hospital, Athens, Greece.
Helen KargaSecond Division of Endocrinology and Metabolism, Alexandra Hospital, Athens, Greece.
Alexandra Hospital · GRGeneral-Maternity District Hospital Helena Venizelou · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntenatal corticosteroid therapy recently has been considered for term and near-term infants, in addition to preterm infants, delivered by elective cesarean section, with the aim of preventing an adverse respiratory outcome.

objectivesThe objective of this study was to investigate hormonal and metabolic effects of antenatal betamethasone when administered to term fetuses.

methodsCord blood levels of cortisol, C-peptide, insulin-like growth factor I and its binding protein 3, and 5 more analytes including glucose were measured in singleton newborns of over 35 weeks of gestational age. In anticipation of a cesarean delivery, the mother was either treated or not treated with 12 mg of intramuscularly administered antenatal betamethasone approximately 24 hours prior to birth. Babies of comparable gestational age, sex, and nutritional status who were not treated antenatally served as controls.

resultsCord serum cortisol levels of the betamethasone-treated fetuses were suppressed to <10% of that of untreated controls (median levels of 11.6 nmol/L vs. 138.2 nmol/L, respectively), and their C-peptide and glucose levels were significantly higher (2.85 mcg/L vs. 1.19 mcg/L, respectively, p < 0.0001; and 62.5 mg/dL vs. 56.0 mg/dL, respectively, p = 0.01).

conclusionsProphylactic betamethasone therapy causes immediate hormonal alterations, which might interfere with the metabolic adaptation of the newborn. This issue deserves thorough investigation.

Indexed as

antenatal corticosteroidsbetamethasonehyperinsulinemiahypoglycemianeonate

Identifiers

PMID25964731
PMCPMC4418681
OpenAlexW1802377457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.